| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/12/12 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
42 |
| 08/09/12 | 8-K | Current report filing |
|
5 | |
| 07/23/12 | 8-K | Current report filing |
|
11 | |
| 07/11/12 | 8-K | Current report filing |
|
5 | |
| 07/09/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/03/12 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
105 | |
| 07/03/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/02/12 | EFFECT | Notice of Effectiveness |
|
1 | |
| 07/02/12 | 8-K | Current report filing |
|
5 | |
| 06/27/12 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.